Encompass Health

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984, and is headquartered in Birmingham, AL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Encompass Health reports robust Q4 performance amidst operational challenges

Encompass Health delivered a strong performance in Q4 2022, showcasing financial growth, effective cost management, and strategic investments in hospital expansions.
While facing challenges such as administrative delays in de novo hospitals and fluctuations in case mix, the company remains focused on leveraging opportunities in market density and regulatory engagement.
With a clear focus on financial stability, growth opportunities, and strategic planning, Encompass Health aims to navigate industry challenges and drive future success.

Encompass Health reports strong Q1 earnings, eyes growth opportunities

Encompass Health (EHC) delivered a robust performance in Q1 2023, showcasing financial growth and operational efficiency.
While facing challenges in labor expenses and capacity constraints, the company remains focused on growth strategies and maintaining strong financial performance.
With raised guidance for 2023 and investments in technology, Encompass Health is poised to capitalize on opportunities for market expansion and improved patient outcomes.

Encompass Health reports robust Q2 earnings, eyes Medicare Advantage growth

Encompass Health's Q2 performance showcased strong revenue and EBITDA growth, driven by volume increases and cost efficiencies. The company's focus on strategic investments, capacity expansions, and optimizing Medicare Advantage revenues positions it well for future growth. Challenges in managing occupancy rates and potential Medicare payment structure changes require careful monitoring.

Encompass Health reports robust Q3 results amid labor cost reductions

Encompass Health's Q3 performance showcased strong revenue growth, operational efficiency, and effective cost management strategies.
The company's focus on key patient categories and capacity expansions position it well for future growth and market relevance.
While challenges like labor market dynamics persist, Encompass Health's strategic initiatives and financial outlook remain positive.

Encompass Health reports robust Q4 performance amidst growth investments

Encompass Health's Q4 2023 performance reflects strong financial growth, operational efficiency, and strategic investments, positioning the company for continued success.
While challenges such as labor inflation and margin sustainability persist, the company's focus on clinical innovation and readiness for regulatory changes bode well for future growth.
Opportunities in managed care, value-based arrangements, and expansion plans offer Encompass Health avenues for further development and enhancing its value proposition in the healthcare sector.

Encompass Health excels in Q1, poised for strategic growth

Encompass Health's Q1 performance reflects robust growth, operational resilience, and strategic foresight amidst industry challenges.
The company's focus on clinical excellence, capacity expansion, and financial discipline positions it for sustained success and market leadership.
While facing cybersecurity risks and regulatory uncertainties, Encompass Health's proactive approach and strong fundamentals mitigate potential challenges.
Encompass Health's upwardly revised guidance, strong patient volume trends, and investment in technology underscore its commitment to growth and innovation.

Encompass Health excels in Q3 2024, poised for growth

Encompass Health's Q3 2024 performance reflects robust revenue growth, operational efficiency, and strategic investments in capacity expansion.
The company's financial strength, resilience to operational challenges, and focus on innovation position it well for future growth opportunities.
While facing potential challenges in a dynamic healthcare landscape, Encompass Health has opportunities to drive growth through strategic initiatives and market expansion.
Overall, Encompass Health's strong performance, prudent financial management, and growth outlook make it a compelling player in the healthcare industry.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.

Encompass Health Corporation (EHC) CEO Mark Tarr on Q4 2021 Results - Earnings Call Transcript

Encompass Health Corporation EHC posted Q4 sales of $1.32 billion, +8.6% Y/Y, in line with the consensus of $1.32. Thousands of new traders are learning the ins and outs on how to find profitable trades every day with Benzinga Trading School.

Why Are Encompass Health Shares Tanking Today Premarket?

Encompass Health (EHC) delivered earnings and revenue surprises of -8.49% and 1.09%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Encompass Health (EHC) Q4 Earnings Lag Estimates

BIRMINGHAM, Ala., Feb. 1, 2022 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home health and hospice agencies, today reported its results of operations for the fourth quarter and full year ended December 31, 2021.

Encompass Health reports results for fourth quarter 2021 and issues full-year 2022 guidance

BIRMINGHAM, Ala. and MIAMI , Feb. 1, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC), a national leader in integrated post-acute healthcare services, and Baptist Health South Florida are pleased to announce an expanded joint venture agreement to include the Baptist Health home health agency in Miami, Florida.

Encompass Health and Baptist Health South Florida expand home health joint venture in Miami, Florida

BIRMINGHAM, Ala., Jan. 25, 2022 /PRNewswire/ -- Encompass Health Corporation ("Encompass Health" or the "Company") (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home health and hospice agencies, today announced that it has received the required consents (the "Required Consents") from holders of its 4.500% Senior Notes due 2028 (the "2028 Notes"), 4.750% Senior Notes due 2030 (the "2030 Notes") and 4.625% Senior Notes due 2031 (the "2031 Notes" and together with the 2028 Notes and 2030 Notes, the "Notes") to certain proposed amendments (the "Proposed Amendments") described in the Consent Solicitation Statement, dated December 9, 2021 (as amended on December 16, 2021, January 12, 2022, January 18, 2022 and January 20, 2022, the "Statement") to the indenture governing the Notes (the "Indenture").

Encompass Health Corporation Announces Execution of Supplemental Indenture for its 4.500% Senior Notes due 2028, 4.750% Senior Notes due 2030 and 4.625% Senior Notes due 2031

BIRMINGHAM, Ala., Jan. 20, 2022 /PRNewswire/ -- Encompass Health Corporation ("Encompass Health" or the "Company") (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home health and hospice agencies, today announced that it is amending its previously announced solicitation of consents (the "Consent Solicitation") from the holders of its 4.500% Senior Notes due 2028 (the "2028 Notes"), 4.750% Senior Notes due 2030 (the "2030 Notes") and 4.625% Senior Notes due 2031 (the "2031 Notes" and together with the 2028 Notes and the 2030 Notes, the "Notes") to certain proposed amendments (the "Proposed Amendments") described in the Consent Solicitation Statement, dated December 9, 2021 (as previously amended on December 16, 2021, January 12, 2022 and January 18, 2022, as amended hereby and as may be further amended or supplemented from time to time, the "Statement") to the indenture governing the Notes (the "Indenture").

Encompass Health Corporation Announces Amendments to Consent Solicitation of Holders of its 4.500% Senior Notes due 2028, 4.750% Senior Notes due 2030 and 4.625% Senior Notes due 2031

Encompass Health (EHC) expects the Enhabit Home Health & Hospice spinoff to be completed in first-half 2022.

Encompass Health (EHC) to Spin Off Home Health & Hospice Unit

Encompass Health Corp (NYSE: EHC) plans to spin off its home health and hospice (HH&H) business into an independent, publicly-traded company and rebrand as Enhabit Home Health & Hospice.  Encompass Health offers facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies.

Encompass Health Plans To Split Into Two - Inpatient Rehabilitation And Home Health & Hospice

BIRMINGHAM, Ala., Jan. 19, 2022 /PRNewswire/ -- Encompass Health Corporation ("Encompass Health" or the "Company") (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home health and hospice agencies, today announced its intention to spin off its home health and hospice business to form an independent, publicly traded company (the "HH&H Business") and to rebrand the HH&H Business as Enhabit Home Health & Hospice.

Encompass Health Corporation Announces Plan to Spin Off Home Health and Hospice Business under the New Brand Enhabit Home Health & Hospice

Encompass Health (EHC) announces plans to construct a rehabilitation facility in Osceola County, FL, which aims to facilitate improved rehabilitation services throughout the region.

Encompass Health (EHC) Unveils Hospital Plan in Osceola County

Allison Transmission Hlds

Aptargroup

Activision Blizzard

Charter Communications

Barrick Gold

Kemper

AT&T

Verizon

Western Union

An artificial intelligence (AI) system identifying high-potential equities has been sharp in the past. Here are its 10 top stocks to watch over the next few months.

Can AI Beat the Market? 10 Stocks to Watch

BIRMINGHAM, Ala., Jan. 13, 2022 /PRNewswire/ -- Encompass Health Corporation ("Encompass Health" or the "Company") (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home health and hospice agencies, today announced the extension of its solicitation of consents (the "Consent Solicitation") from the holders of its 4.500% Senior Notes due 2028, 4.750% Senior Notes due 2030 and 4.625% Senior Notes due 2031 (collectively, the "Notes") to certain proposed amendments (the "Proposed Amendments") described in the Consent Solicitation Statement, dated December 9, 2021 (as previously amended on December 16, 2021, as amended hereby and as may be further amended or supplemented from time to time, the "Statement") to the indenture governing the Notes (the "Indenture").

Encompass Health Corporation Announces Extension of Consent Solicitation of Holders of its 4.500% Senior Notes due 2028, 4.750% Senior Notes due 2030 and 4.625% Senior Notes due 2031

BIRMINGHAM, Ala., Jan. 10, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its fourth quarter ended Dec. 31, 2021, after the market closes on Feb. 1, 2022.

Encompass Health announces date of 2021 fourth quarter earnings call

Encompass Health (EHC) forms a JV with Saint Alphonsus for offering better home health and hospice services across Idaho.

Encompass Health (EHC) Forms JV, Boosts Presence in Idaho

BIRMINGHAM, Ala. and BOISE, Idaho, Jan. 5, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC), a national leader in integrated post-acute healthcare services, and Saint Alphonsus Health System are pleased to announce a new joint venture agreement in Idaho.

Encompass Health and Saint Alphonsus Health System announce home health and hospice joint venture in Idaho

Columbus McKinnon

Comcast

Electronic Arts

East West Bancorp

FedEx

General Motors

Graphic Packaging Hld

Global Payments

Huntsman

Lowe's

MKS Instruments

MasTec

United Therapeutics

Investors looking for stability in the new year may want to consider value stocks. Here are 15 of the best-rated ones heading into 2022.

The 15 Best Value Stocks to Buy for 2022

Encompass Health (EHC) reveals plans to construct an inpatient rehabilitation hospital in Ohio, which aims to facilitate improved rehabilitation services throughout the state.

Encompass Health (EHC) Unveils 40-Bed Hospital Plan in Ohio

BIRMINGHAM, Ala., Dec. 16, 2021 /PRNewswire/ -- Encompass Health Corporation ("Encompass Health" or the "Company") (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home health and hospice agencies, today announced that it has received the required consents from holders of its 5.75% Senior Notes due 2025 (the "2025 Notes") to certain proposed amendments (the "Proposed Amendments") described in the Consent Solicitation Statement, dated December 9, 2021 (the "Statement") to the indenture governing the 2025 Notes (the "Indenture").

Encompass Health Corporation Announces Execution of Supplemental Indenture for its 5.75% Senior Notes due 2025 and Extension of Consent Solicitation of Holders of its 4.500% Senior Notes due 2028, 4.750% Senior Notes due 2030 and 4.625% Senior Notes due 2

BIRMINGHAM, Ala. and STRONGSVILLE, Ohio, Dec. 14, 2021 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a freestanding, 40-bed inpatient rehabilitation hospital near Cleveland, Ohio.

Encompass Health announces plans to build an inpatient rehabilitation hospital in Cleveland, Ohio area

BIRMINGHAM, Ala., Dec. 9, 2021 /PRNewswire/ -- Encompass Health Corporation ("Encompass Health" or the "Company") (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home health and hospice agencies, today announced that it is soliciting consents (the "Consent Solicitation") from the holders of its 5.75% Senior Notes due 2025, 4.500% Senior Notes due 2028, 4.750% Senior Notes due 2030 and 4.625% Senior Notes due 2031 (collectively, the "Notes") commencing on December 9, 2021 (the "Holders") for the adoption of certain proposed amendments as set forth below (the "Proposed Amendments") to the indenture governing the Notes, as supplemented (the "Indenture").

Encompass Health Corporation Announces Consent Solicitation

Encompass Health (EHC) aims to deliver better health outcomes by revealing plans to build an inpatient rehabilitation hospital in Texas.

Encompass Health (EHC) Boosts Texas Presence With Hospital Plan

BIRMINGHAM, Ala. and AMARILLO, Texas, Dec. 3, 2021 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a freestanding, 40-bed inpatient rehabilitation hospital in Amarillo, Texas.

Encompass Health announces plans to build an inpatient rehabilitation hospital in Amarillo, Texas

Encompass Health (EHC) reveals plans to construct a 27-bed hospital in South Carolina aimed at providing high-quality rehabilitative care throughout the state.

News for Encompass Health Stock (EHC)